$EFOR

Everforth (NYSE:EFOR) posts better-than-expected sales in Q3 2026

Everforth (EFOR) reported Q3 2026 revenue of $1.03B, beating estimates by 2%, with adjusted EPS of $1.11, a 6.6% beat. Adjusted EBITDA was $106.3M, a 5.1% beat. Q4 guidance was mixed, with revenue below estimates but EPS above. Operating and free cash flow margins declined year-on-year.

Original reporting
Published Oct 28, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Everforth (NYSE:EFOR) posts better-than-expected sales in Q3 2026 — source image
Decision brief

The 30-second read

$EFORBearishMed
01

Why it matters

The earnings beat on sales and EPS is positive, but the revenue guidance miss may dominate short‑term market reaction, likely leading to a modest sell‑off.

02

Market read

First‑report earnings release with mixed guidance, relevant for traders monitoring industrial sector momentum.

03

What to watch

Management may be targeting cost efficiencies that could improve margins beyond the guidance period.

Relevance 8/10Novelty 8/10Timing: pre‑market tomorrow

Background

Everforth (NYSE:EFOR) posted Q3 2026 results with revenue of $1.03 B versus $1.01 B estimate and adjusted EPS of $1.11 versus $1.04 estimate. Guidance for Q4 revenue was $980 M, below the $987.2 M consensus, while EPS guidance was slightly above expectations.

Company-level read

Ticker impact

$EFORBearishHigh confidence
Context

Everforth reported Q3 sales beat estimates and EPS beat, but gave Q4 revenue guidance below consensus.

Expected impact

likely downside pressure as the market prices in the revenue guidance miss despite the EPS beat

Evidence & confidence

Revenue guidance below expectations typically outweighs a modest EPS beat for short‑term price action.

Market effects

May prompt a reassessment of peers in the industrial equipment sector regarding demand outlook.

North American industrial stocks could see modest pullback.

Limited to markets tracking US industrial earnings.

Counterpoint

The EPS beat could signal underlying profitability strength, suggesting a potential bounce if revenue guidance is revised.

Key entities

  • Everforth

    Industrial equipment manufacturer listed on NYSE.

Related articles

$EFORMedAI 8/10

Everforth Inc (EFOR) Q3 2026 Earnings Call Highlights: Revenue and Adjusted EBITDA

Everforth Inc (EFOR) reported Q3 2026 earnings with revenue and adjusted EBITDA beating estimates. Q4 guidance projects revenue of $965M-$995M, a sequential decline, and adjusted EBITDA margin of 9.6%-10.4%. Federal and commercial segments showed modest growth. The company aims for a 12.5% EBITDA margin by 2028, citing growth and cost savings. Management discussed hiring, margins, federal contracting, and strategic investments during the earnings call.

$EFORMed

What ASGN (EFOR) Said on Its Q3 Earnings Call

ASGN (EFOR) reported Q3 revenue growth in technology, media, telecommunications, and business services. Key customer engagements include Workday and Salesforce projects. Gross margin was 28.3%, with $46.5M in free cash flow. The company repaid $52.8M in debt and projects Q4 revenue of $965M-$995M. ASGN targets adjusted EBITDA margin of 12.5% by 2028.

$EFORMed

Everforth: Q3 Earnings Snapshot

Everforth, Inc. (EFOR) reported Q3 net income of $23.1M, or 56 cents per share, with adjusted earnings of $1.11 per share. Revenue was $1.03B. The company expects full-year earnings between 95 cents and $1.11 per share.

$EFORHighAI 8/10

Everforth earnings beat by $0.09, revenue topped estimates

Everforth (EFOR) reported Q3 EPS of $1.11, beating estimates by $0.09, with revenue at $1.03B, exceeding expectations. The company guided Q4 2026 EPS to $0.95-$1.11 and revenue to $965M-$995M, both below consensus. EFOR's stock is up 36.22% over 3 months but down 13.04% year-over-year, with a 'good performance' financial health score according to InvestingPro.